Comparison

Cetuximab (anti-EGFR) European Partner

Manufacturer TargetMol
Category
Type Molecules
Specific against other
Amount 5mg
Item no. TMO-T9905-5mg
Targets EGFR
CASRN 205923-56-4
eClass 6.1 32169090
eClass 9.0 32169090
Available
Short Description
Cetuximab (anti-EGFR) a novel molecular-targeted agentis an inhibitor of EGFR monoclonal humanized antibody interacting with the extracellular binding site of EGFR to block ligand stimulation.
Shipping
cool pack
Storage
-20°
Target names or alias
Cetuximab (anti-EGFR) , C225
Molecular Weight
152kd
Pathway
Tyrosine Kinase/Adaptors|||JAK/STAT signaling|||Angiogenesis
Target
EGFR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Delivery expected until 5/9/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close